EORTC-20991-LYMG

Diffuse large B cell and peripheral T cell non-Hodgkin's lymphomas in the elderly. Influence of prolonged oral etoposide added to CHOP combination chemotherapy in patients with good physiological status. An EORTC phase II-III trial including geriatric assessment and quality of life.
Trial StatusAll trial activities ended
DatesDate of activation: 19-Mar-03
Closed on : 13-Aug-04
Data management at EORTCFull
Phase2-3
Randomized trialYes
TypeHemato-malign
Targeted Sample size126
Number of steps1
DrugCyclophosphamide
Doxorubicin
Vincristine
Study Staff
Type of cancerNon Hodgkins Lymphoma
Participating GroupsEORTC Lymphoma Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00060385
EudraCT
Protocol documents in PDF
(requires password)
Study documentation
@
Back to Protocol section